Exagen Inc. Common Stock (XGN)

Price$4.29

Value ScoreD

Growth ScoreB

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-53.62%

Price vs S&P 500 (4W)45.43%

VGM Score45.40

Market Capitalization$109.69M

All Metrics

Book Value / Share (Quarterly)$0.60

P/TBV (Annual)0.62x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)13.48%

Cash Flow / Share (Quarterly)$-0.59

Price vs S&P 500 (YTD)-37.60%

Gross Margin (TTM)58.32%

Net Profit Margin (TTM)-29.49%

EPS (TTM)$-0.88

10-Day Avg Trading Volume0.54M

EPS Excl Extra (TTM)$-0.88

Revenue Growth (5Y)9.66%

EPS (Annual)$-0.93

ROI (Annual)-45.92%

Gross Margin (Annual)58.28%

Net Profit Margin (5Y Avg)-52.37%

Cash / Share (Quarterly)$0.89

Revenue Growth QoQ (YoY)11.67%

ROA (Last FY)-34.39%

Revenue Growth TTM (YoY)20.55%

EBITD / Share (TTM)$-0.53

ROE (5Y Avg)-104.06%

Operating Margin (TTM)-21.08%

Cash Flow / Share (Annual)$-0.62

P/B Ratio7.60x

P/B Ratio (Quarterly)5.00x

Net Income / Employee (Annual)$-92,400

EV / Revenue (TTM)1.67x

Net Interest Coverage (TTM)-3.94x

ROA (TTM)-34.83%

EPS Incl Extra (Annual)$-0.93

Current Ratio (Annual)3.45x

Quick Ratio (Quarterly)2.97x

3-Month Avg Trading Volume0.42M

52-Week Price Return-40.33%

Revenue / Employee (TTM)$316,600

Tangible BV / Share (Quarterly)$1.62

P/S Ratio (Annual)1.65x

Asset Turnover (Annual)1.15x

52-Week High$12.23

Operating Margin (5Y Avg)-48.09%

EPS Excl Extra (Annual)$-0.93

CapEx CAGR (5Y)6.86%

26-Week Price Return-45.70%

Quick Ratio (Annual)3.04x

13-Week Price Return33.23%

Total Debt / Equity (Annual)1.49x

Current Ratio (Quarterly)3.47x

Enterprise Value$113.95M

Revenue / Share Growth (5Y)-1.46%

Asset Turnover (TTM)1.18x

Book Value / Share Growth (5Y)-25.41%

Revenue / Employee (Annual)$308,200

Pretax Margin (Annual)-29.89%

Cash / Share (Annual)$1.41

3-Month Return Std Dev104.74%

Gross Margin (5Y Avg)55.62%

Net Income / Employee (TTM)$-93,400

ROE (Last FY)-114.34%

Net Interest Coverage (Annual)-2.98x

EPS Basic Excl Extra (Annual)$-0.93

Receivables Turnover (TTM)4.48x

Total Debt / Equity (Quarterly)1.79x

EPS Incl Extra (TTM)$-0.88

Receivables Turnover (Annual)7.12x

ROI (TTM)-46.89%

P/S Ratio (TTM)1.60x

Pretax Margin (5Y Avg)-52.38%

Revenue / Share (Annual)$3.09

Tangible BV / Share (Annual)$2.57

Price vs S&P 500 (52W)-64.70%

Year-to-Date Return-29.44%

5-Day Price Return-19.81%

EPS Normalized (Annual)$-0.93

ROA (5Y Avg)-37.31%

Net Profit Margin (Annual)-29.97%

Month-to-Date Return-13.86%

Cash Flow / Share (TTM)$-1.45

EBITD / Share (Annual)$-0.57

Operating Margin (Annual)-21.58%

LT Debt / Equity (Annual)1.28x

ROI (5Y Avg)-47.96%

LT Debt / Equity (Quarterly)1.54x

EPS Basic Excl Extra (TTM)$-0.88

P/TBV (Quarterly)0.96x

P/B Ratio (Annual)7.78x

Pretax Margin (TTM)-29.36%

Book Value / Share (Annual)$0.76

Price vs S&P 500 (13W)24.98%

Beta2.08x

Revenue / Share (TTM)$2.87

ROE (TTM)-113.53%

52-Week Low$2.59

vGradeD

gGradeB

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.20est. -0.24

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.17

4.18

Industry Peers — Health Services(28)

Symbol	Value Score	Growth Score	Momentum Score	Price
XGNExagen Inc. Common Stock	D	B	D	$4.29
NTRANatera, Inc. Common Stock	F	A	C	$215.31
DGXQuest Diagnostics Inc.	C	D	C	$200.29
LHLabcorp Holdings Inc.	C	D	C	$265.15
EXASExact Sciences Corp	F	B	B	$0.00
GHGuardant Health, Inc. Common Stock	F	A	B	$125.61
CAICaris Life Sciences, Inc. Common Stock	F	A	D	$16.49
CELCCelcuity Inc. Common Stock	—	—	C	$88.28
RDNTRadNet, Inc. Common Stock	D	C	C	$54.34
VCYTVeracyte, Inc.	D	A	B	$48.73
GRALGRAIL, Inc. Common Stock	D	A	C	$59.98

About

Exagen Inc is a commercial-stage diagnostics company offering ten testing solutions under the Avise brand for autoimmune rheumatic diseases (ARDs). The company's products enable community rheumatologists to accurately diagnose and monitor ARD patients while optimizing treatment decisions. Exagen addresses unmet diagnostic needs in a key therapeutic area.